List of SBIR/STTR awards granted to MBC Pharma, Inc.

List of SBIR/STTR awards granted to MBC Pharma, Inc.

List of SBIR/STTR awards granted to Essential Research, Inc.

List of SBIR/STTR awards granted to Darcy Solutions Inc.

List of SBIR/STTR awards granted to Mti Systems, Inc.

List of Secure Channels Inc. patents

List of WalkMe patents

where

SBIR/STTR Award Recipient

is

‌

MBC Pharma, Inc.

	Name	Description	SBIR/STTR Award Recipient	Government Agency	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
	‌ MBC Pharma, Inc. SBIR Phase I Award, August 2017	A SBIR Phase I contract was awarded to MBC Pharma, Inc. in August, 2017 for $594,202.0 USD from the U.S. Department of Health & Human Services.	‌ MBC Pharma, Inc.			SBIR	1R43AI127359-01A1	Phase I	594,202	August 7, 2017	sbir.gov/node/1322369
	‌ MBC Pharma, Inc. SBIR Phase I Award, February 2016	A SBIR Phase I contract was awarded to MBC Pharma, Inc. in February, 2016 for $301,877.0 USD from the U.S. Department of Health & Human Services.	‌ MBC Pharma, Inc.			SBIR	1R43CA203166-01	Phase I	301,877	February 1, 2016	sbir.gov/node/1163521
	‌ MBC Pharma, Inc. SBIR Phase II Award, September 2017	A SBIR Phase II contract was awarded to MBC Pharma, Inc. in September, 2017 for $2,135,327.0 USD from the U.S. Department of Health & Human Services.	‌ MBC Pharma, Inc.			SBIR	2R44CA203166-02	Phase II	2,135,327	September 12, 2017	sbir.gov/node/1323883
	‌ MBC Pharma, Inc. STTR Phase I Award,	A STTR Phase I contract was awarded to MBC Pharma, Inc. for $100,000.0 USD from the U.S. Department of Health & Human Services.	‌ MBC Pharma, Inc.			STTR	1R41CA097577-01	Phase I	100,000		sbir.gov/content/novel-bisphosphonates-breast-cancer-therapy-0
	‌ MBC Pharma, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to MBC Pharma, Inc. for $100,000.0 USD from the U.S. Department of Health & Human Services.	‌ MBC Pharma, Inc.			SBIR	1R43CA121482-01A1	Phase I	100,000		sbir.gov/content/novel-bisphosphonates-prostate-cancer-therapy-0
	‌ MBC Pharma, Inc. STTR Phase I Award,	A STTR Phase I contract was awarded to MBC Pharma, Inc. for $100,045.0 USD from the U.S. Department of Health & Human Services.	‌ MBC Pharma, Inc.			STTR	1R41AR050298-01A1	Phase I	100,045		sbir.gov/content/prevention-osteoporosis-novel-bisphosphonates-0
	‌ MBC Pharma, Inc. STTR Phase II Award,	A STTR Phase II contract was awarded to MBC Pharma, Inc. for $758,509.0 USD from the U.S. Department of Health & Human Services.	‌ MBC Pharma, Inc.			STTR	2R44CA105583-02	Phase II	758,509		sbir.gov/content/novel-bisphosphonates-multiple-myeloma-therapy-2
	‌ MBC Pharma, Inc. SBIR Phase II Award,	A SBIR Phase II contract was awarded to MBC Pharma, Inc. for $758,509.0 USD from the U.S. Department of Health & Human Services.	‌ MBC Pharma, Inc.			SBIR	2R44CA105583-02	Phase II	758,509		sbir.gov/node/1070405
	‌ MBC Pharma, Inc. SBIR Phase II Award,	A SBIR Phase II contract was awarded to MBC Pharma, Inc. for $1,795,050.0 USD from the U.S. Department of Health & Human Services.	‌ MBC Pharma, Inc.			SBIR	2R44CA121482-02	Phase II	1,795,050		sbir.gov/node/7159
	‌ MBC Pharma, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to MBC Pharma, Inc. for $100,045.0 USD from the U.S. Department of Health & Human Services.	‌ MBC Pharma, Inc.			SBIR	1R41AR050298-01A1	Phase I	100,045		sbir.gov/node/1066503
	‌ MBC Pharma, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to MBC Pharma, Inc. for $100,000.0 USD from the U.S. Department of Health & Human Services.	‌ MBC Pharma, Inc.			SBIR	1R41CA105583-01	Phase I	100,000		sbir.gov/node/1066083
	‌ MBC Pharma, Inc. STTR Phase I Award,	A STTR Phase I contract was awarded to MBC Pharma, Inc. for $100,000.0 USD from the U.S. Department of Health & Human Services.	‌ MBC Pharma, Inc.			STTR	1R41CA105583-01	Phase I	100,000		sbir.gov/content/novel-bisphosphonates-multiple-myeloma-therapy-0
	‌ MBC Pharma, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to MBC Pharma, Inc. for $241,512.0 USD from the U.S. Department of Health & Human Services.	‌ MBC Pharma, Inc.			SBIR	1R43CA167964-01A1	Phase I	241,512		sbir.gov/node/677594

13 results

0 selected

13 results

0 selected